Acknowledgments |
|
viii | |
1 Introduction to the Classification of Lymphoma |
|
1 | (13) |
|
|
Working Formulation classifications |
|
|
1 | (1) |
|
WHO, REAL, EORTC, the Combined WHO/EORTC classifications |
|
|
2 | (5) |
|
|
7 | (1) |
|
|
8 | (1) |
|
Appendix: Definitions of key terms and techniques |
|
|
9 | (5) |
2 The Therapy of Cutaneous T Cell Lymphoma |
|
14 | (9) |
|
|
|
|
|
14 | (1) |
|
Diagnostic work-up and staging procedures |
|
|
14 | (1) |
|
|
15 | (1) |
|
Goals of therapy in advanced-stage CTCL |
|
|
16 | (1) |
|
Extracorporeal photopheresis (ECP) |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
17 | (1) |
|
|
18 | (1) |
|
|
18 | (1) |
|
Histone deacetylase inhibitors (HDACi) |
|
|
19 | (1) |
|
Antibody drug conjugates (ADC) |
|
|
19 | (1) |
|
|
19 | (1) |
|
Investigational therapies |
|
|
20 | (1) |
|
TLR agonists and cytokines |
|
|
20 | (1) |
|
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) |
|
|
20 | (1) |
|
|
21 | (2) |
3 Molecular Analysis in Cutaneous Lymphoid Proliferation |
|
23 | (14) |
|
|
|
|
|
23 | (1) |
|
Immunoglobulin and T cell receptor structure |
|
|
23 | (1) |
|
PCR design for determination of clonality |
|
|
24 | (1) |
|
Detection of PCR products for clonality |
|
|
24 | (1) |
|
|
25 | (1) |
|
The value and utility of molecular diagnostics in primary cutaneous lymphomas |
|
|
26 | (1) |
|
Limitations of clonality assessment by PCR |
|
|
27 | (2) |
|
|
29 | (7) |
|
|
36 | (1) |
4 Benign Lymphocytic Infiltrates |
|
37 | (22) |
|
|
37 | (1) |
|
Spongiotic and eczematous dermatitis |
|
|
37 | (3) |
|
Other spongiotic/eczematous tissue reactions |
|
|
40 | (1) |
|
Other causes of subacute eczematous dermatitis |
|
|
40 | (2) |
|
Interface dermatitis: cell-poor vacuolar interface dermatitis |
|
|
42 | (4) |
|
Interface dermatitis: lichenoid pattern |
|
|
46 | (5) |
|
Diffuse and nodular lymphocytic dermal infiltrates without atypia |
|
|
51 | (2) |
|
Diffuse and nodular lymphocytic infiltrates associated with autoimmune disease |
|
|
53 | (4) |
|
|
57 | (2) |
5 Reactive Lymphomatoid Tissue Reactions Mimicking Cutaneous T and B Cell Lymphoma |
|
59 | (30) |
|
Lymphomatoid drug eruptions |
|
|
59 | (2) |
|
Molecular profile of lymphomatoid drug eruptions |
|
|
61 | (1) |
|
Pathogenetic basis of lymphomatoid drug reactions |
|
|
62 | (1) |
|
Reactive lymphomatoid lesions encountered in lesions of collagen vascular disease |
|
|
63 | (4) |
|
Angiomatous Variants of Pseudolymphoma |
|
|
67 | (2) |
|
|
69 | (17) |
|
|
86 | (3) |
6 Precursor Lesions of Cutaneous T Cell Lymphoma |
|
89 | (45) |
|
Cutaneous T cell lymphoid dyscrasia |
|
|
89 | (1) |
|
Large plaque parapsoriasis |
|
|
90 | (1) |
|
Hypopigmented interface T cell dyscrasia: a unique indolent T cell dyscrasia |
|
|
91 | (1) |
|
Pigmented purpuric dermatosis (PPD) |
|
|
92 | (2) |
|
|
94 | (2) |
|
Idiopathic erythroderma (pre-Sezary) |
|
|
96 | (1) |
|
Syringolymphoid hyperplasia with alopecia |
|
|
96 | (1) |
|
Folliculotropic T cell lymphocytosis/pilotropic T cell dyscrasia |
|
|
97 | (1) |
|
Idiopathic follicular mucinosis/alopecia mucinosa |
|
|
98 | (1) |
|
Keratoderma-like T cell dyscrasia |
|
|
99 | (1) |
|
Atypical lymphocytic lobular panniculitis |
|
|
100 | (2) |
|
|
102 | (30) |
|
|
132 | (2) |
7 Marginal Zone Lymphoma and Other Related Post Germinal Center B Cell Lymphoproliferative Disorders of The Skin |
|
134 | (35) |
|
|
134 | (6) |
|
Blastic marginal zone lymphoma |
|
|
140 | (1) |
|
Epidermotropic marginal zone lymphoma |
|
|
140 | (1) |
|
|
141 | (1) |
|
Primary cutaneous plasmacytoma |
|
|
142 | (3) |
|
|
145 | (21) |
|
|
166 | (3) |
8 Primary Cutaneous Follicle Center Cell Lymphoma |
|
169 | (18) |
|
|
169 | (1) |
|
|
169 | (2) |
|
|
171 | (1) |
|
|
172 | (1) |
|
|
172 | (1) |
|
|
172 | (2) |
|
|
174 | (11) |
|
Additional molecular and cytogenetic study |
|
|
185 | (1) |
|
|
186 | (1) |
9 Primary Cutaneous Diffuse Large B-Cell Lymphoma Including the Leg Type and Precursor B Cell Lymphoblastic Lymphoma |
|
187 | (31) |
|
Primary cutaneous diffuse large B cell lymphoma |
|
|
187 | (10) |
|
Systemic diffuse large B cell lymphomas with a propensity to involve the skin |
|
|
197 | (3) |
|
|
200 | (10) |
|
Additional light microscopic, phenotypic, molecular, cytogenetic studies |
|
|
210 | (5) |
|
|
215 | (3) |
10 Intravascular Lymphoma |
|
218 | (7) |
|
|
218 | (1) |
|
Light microscopic findings |
|
|
219 | (1) |
|
|
219 | (1) |
|
Molecular and cytogenetic studies |
|
|
219 | (1) |
|
|
219 | (1) |
|
|
219 | (1) |
|
Intravascular anaplastic large cell lymphoma |
|
|
219 | (1) |
|
Benign intravascular proliferations of histiocytes and reactive T cells |
|
|
220 | (1) |
|
|
221 | (3) |
|
|
224 | (1) |
11 Cutaneous Mantle Cell Lymphoma |
|
225 | (11) |
|
|
225 | (1) |
|
Light microscopic findings |
|
|
225 | (1) |
|
|
226 | (1) |
|
|
227 | (1) |
|
|
227 | (1) |
|
|
227 | (2) |
|
|
229 | (4) |
|
Additional molecular and cytogenetic studies |
|
|
233 | (1) |
|
|
234 | (2) |
12 Mycosis Fungoides and Sezary Syndrome |
|
236 | (38) |
|
|
236 | (1) |
|
|
236 | (7) |
|
Sezary syndrome and erythrodermic mycosis fungoides |
|
|
243 | (8) |
|
Large cell transformation of mycosis fungoides |
|
|
251 | (3) |
|
Extracutaneous involvement in mycosis fungoides |
|
|
254 | (5) |
|
|
259 | (12) |
|
|
271 | (3) |
13 CD3O-Positive Lymphoproliferative Disorders Including Lymphomatoid Papulosis, Borderline CD3O-Positive Lymphoproliferative Disease, Anaplastic Large Cell Lymphoma, T-Cell-Rich CD3O-Positive Large B Cell Lymphoma |
|
274 | (38) |
|
|
274 | (1) |
|
|
274 | (4) |
|
CD8+ lymphomatoid papulosis, including the type D variant |
|
|
278 | (1) |
|
Type E lymphomatoid papulosis (Case vignette 15) |
|
|
278 | (1) |
|
Borderline CD30-positive lymphoproliferative disorders (type C LYP) (Case vignette 9) |
|
|
279 | (1) |
|
Lymphomatoid papulosis with a rearrangement of chromosome 6p25.3 |
|
|
279 | (1) |
|
Cutaneous anaplastic large cell lymphoma |
|
|
280 | (2) |
|
|
282 | (1) |
|
Additional unusual histologic variants of anaplastic large cell lymphoma |
|
|
282 | (1) |
|
Breast-implant-associated anaplastic large cell lymphoma |
|
|
282 | (1) |
|
Intravascular anaplastic large cell lymphoma |
|
|
282 | (1) |
|
Sarcomatoid anaplastic large cell lymphoma (Case vignette 14) |
|
|
283 | (2) |
|
CD30-positive large B cell lymphoma |
|
|
285 | (1) |
|
|
286 | (23) |
|
|
309 | (3) |
14 CD4+ Peripheral T Cell Lymphoma, Not Otherwise Specified, Including Primary Cutaneous Cd4+ Small/ Medium-Sized Pleomorphic T Cell Lymphoma |
|
312 | (22) |
|
|
312 | (1) |
|
Primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma |
|
|
312 | (1) |
|
CD30-negative large cell T cell lymphoma |
|
|
313 | (1) |
|
Cutaneous follicular helper T cell lymphoma |
|
|
314 | (1) |
|
Overview of overall prognosis of primary cutaneous peripheral T cell lymphoma, unspecified |
|
|
315 | (4) |
|
Evolution of the nomenclature of primary cutaneous CD4+ small/medium-sized pleomorphic T cell lymphoma |
|
|
319 | (1) |
|
|
320 | (13) |
|
|
333 | (1) |
15 Subcutaneous Panniculitis-Like T Cell Lymphoma |
|
334 | (17) |
|
|
334 | (2) |
|
|
336 | (1) |
|
|
337 | (1) |
|
|
337 | (1) |
|
|
337 | (3) |
|
|
340 | (9) |
|
|
349 | (2) |
16 CD8 T Cell Lymphoproliferative Disease of the Skin |
|
351 | (26) |
|
|
351 | (1) |
|
|
351 | (1) |
|
Classification of primary CD8+ cutaneous T cell lymphomas |
|
|
352 | (1) |
|
Histomorphology of primary cutaneous CD8+ T cell lymphoma: primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma, CD8+ variants of peripheral T cell lymphoma, NOS, including primary cutaneous CD8+ granulomatous T cell lymphoma |
|
|
353 | (1) |
|
CD8 variant of lymphomatoid papulosis and other related CD30-positive T cell lymphoproliferative disorders of CD8 subtype |
|
|
354 | (1) |
|
Light microscopic findings |
|
|
354 | (1) |
|
Indolent CD8 positive lymphoid proliferation of the face and other body sites including acral surfaces |
|
|
355 | (1) |
|
CD8 prolymphocytic leukemia |
|
|
355 | (1) |
|
CD8 pseudolymphoma related to underlying HIV disease |
|
|
356 | (1) |
|
Drug-associated CD8+ pseudolymphoma |
|
|
356 | (1) |
|
Actinic reticuloid as a unique form of CD8+ pseudolymphoma |
|
|
356 | (1) |
|
|
357 | (18) |
|
|
375 | (2) |
17 Nasal and Related Extranodal Natural Killer Cell/T Cell Lymphomas and Blastic Plasmacytoid Dendritic Cell Neoplasm |
|
377 | (27) |
|
|
377 | (1) |
|
Biology of NK and NK-like T cells |
|
|
377 | (2) |
|
|
379 | (1) |
|
|
379 | (1) |
|
Nasal type NK/T cell lymphoma |
|
|
380 | (1) |
|
Aggressive NK cell lymphoma |
|
|
380 | (2) |
|
Role of Epstein-Barr virus in the evolution of NK/T cell lymphomas |
|
|
382 | (1) |
|
Blastic plasmacytoid dendritic cell neoplasm |
|
|
382 | (1) |
|
CD56-positive γ δ lymphoma involving the subcutaneous fat |
|
|
383 | (1) |
|
Chronic granular lymphocytosis/large granular cell leukemia |
|
|
384 | (1) |
|
Natural killer-like CD4+ T cell lymphoma |
|
|
384 | (1) |
|
EBV-associated NK/T cell lymphomas of the elderly |
|
|
385 | (1) |
|
Hydroa vaccineforme (HV)-like lymphoma |
|
|
385 | (1) |
|
Cutaneous intravascular NK T cell lymphoma |
|
|
386 | (1) |
|
|
387 | (14) |
|
|
401 | (3) |
18 Primary Cutaneous γ δ T Cell Lymphoma |
|
404 | (11) |
|
|
404 | (5) |
|
|
409 | (2) |
|
Additional supplemental figures |
|
|
411 | (3) |
|
|
414 | (1) |
19 Epstein-Barr Virus-Associated Lymphoproliferative Disease |
|
415 | (20) |
|
|
415 | (1) |
|
Hydroa vacciniforme-like EBV-associated T cell lymphoproliferative disease/mosquito bite hypersensitivity |
|
|
416 | (4) |
|
EBV+ cutaneous B cell lymphoproliferative disorder of the elderly |
|
|
420 | (1) |
|
EBV-associated mucocutaneous ulcer |
|
|
421 | (1) |
|
EBV + T cell lymphoproliferative disease of the elderly |
|
|
421 | (1) |
|
General principles regarding EBV-associated lymphomagenesis |
|
|
421 | (1) |
|
Pathogenetic link between EBV-associated B cell lymphoma and iatrogenic immune dysregulation related to either methotrexate or cyclosporine |
|
|
421 | (2) |
|
|
423 | (9) |
|
|
432 | (3) |
20 Hodgkin Lymphoma of the Skin |
|
435 | (14) |
|
|
435 | (1) |
|
Subtypes of Hodgkin lymphoma |
|
|
436 | (11) |
|
|
447 | (2) |
21 Chronic Lymphocytic Leukemia of B Cell and T Cell Prolymphocytic Leukemia |
|
449 | (24) |
|
B cell chronic lymphocytic leukemia |
|
|
449 | (3) |
|
T cell prolymphocytic leukemia |
|
|
452 | (3) |
|
|
455 | (16) |
|
|
471 | (2) |
22 Adult T Cell Leukemia/Lymphoma |
|
473 | (13) |
|
|
473 | (1) |
|
|
474 | (1) |
|
|
475 | (1) |
|
|
475 | (1) |
|
Infective dermatitis of childhood |
|
|
476 | (1) |
|
|
477 | (7) |
|
|
484 | (2) |
23 Angioimmunoblastic Lymphadenopathy/Angioimmunoblastic T Cell Lymphoma |
|
486 | (13) |
|
|
486 | (1) |
|
Light microscopic findings |
|
|
487 | (1) |
|
|
488 | (1) |
|
|
488 | (1) |
|
|
489 | (2) |
|
|
491 | (6) |
|
|
497 | (2) |
24 Lymphomatoid Granulomatosis |
|
499 | (8) |
|
|
499 | (1) |
|
|
499 | (1) |
|
|
500 | (1) |
|
|
501 | (1) |
|
|
501 | (1) |
|
|
501 | (1) |
|
|
502 | (1) |
|
|
503 | (3) |
|
|
506 | (1) |
25 Cutaneous Infiltrates of Myeloid Derivation |
|
507 | (34) |
|
|
507 | (1) |
|
|
507 | (2) |
|
Clonal histiocytopathy syndromes |
|
|
509 | (5) |
|
Histiocytopathy of factor XIIIA perivascular dermal dendritic cell origin |
|
|
514 | (3) |
|
|
517 | (20) |
|
|
537 | (4) |
Index |
|
541 | |